|
2024
|
Invention
|
Annexin a5 protein as a combination therapy with an anti-vegf agent for use in the treatment of m... |
|
2023
|
Invention
|
Process of manufacture of annexin v.
The present invention provides a process for the recovery a... |
|
|
Invention
|
Monomeric annexin a5 for use in the treatment of macular oedema or retinal vein occlusion.
The i... |
|
|
Invention
|
Monomeric annexin a5 for use in the treatment of macular oedema or retinal vein occlusion. The in... |
|
|
Invention
|
Monomeric annexin a5 for use in the treatment of macular oedema or retinal vein occlusion |
|
2021
|
Invention
|
Process of manufacture of annexin v. The present invention provides a process for the recovery an... |
|
|
Invention
|
Oxidized cardiolipin as a pro-inflammatory factor.
Low levels of antibodies reactive with oxidis... |
|
2019
|
Invention
|
Therapeutic and prophylactic methods, uses and compositions comprising annexin a5.
The presen... |
|
2018
|
Invention
|
Therapeutic compositions. The invention relates to novel methods, uses and compositions for the p... |
|
|
Invention
|
Methods for treating restenosis using annexin a5.
A method for the prophylaxis or treatment of r... |
|
2017
|
Invention
|
Therapeutic and prophylactic methods, uses and compositions comprising anexin a5.
The present in... |
|
2016
|
Invention
|
A process for the recovery and/or purification of annexin a5 protein. The present invention... |
|
|
Invention
|
A process for the recovery and/or purification of annexin as protein. The present invention provi... |
|
|
Invention
|
Compounds and methods for the treatment of vascular disease. The present invention relates to a m... |
|
|
Invention
|
Methods for treating restenosis using annexin a5. A method for the prophylaxis or treatment of re... |
|
2015
|
Invention
|
Therapeutic composition comprising annexin v.
The present invention provides Annexin A5 for use ... |
|
|
Invention
|
Therapeutic composition comprising annexin v. The present invention provides Annexin A5 for use i... |
|
2013
|
Invention
|
Oxidized cardiolipin as a pro-inflammatory factor. Low levels of antibodies reactive with oxidize... |
|
2009
|
Invention
|
Compounds and methods for the prevention or treatment of restenosis comprising annexin a5. ... |
|
2008
|
Invention
|
Use of annexin a5 for the treatment of vascular disease. The present invention relates to a... |
|
2005
|
Invention
|
Annexin v for preventing atherothrombosis and plaque rupture.
Atherosclerosis can be viewed as a... |
|
|
Invention
|
Annexin v for preventing atherothrombois and plaque rupture. Atherosclerosis can be viewed ... |
